About this trial
Objective To pragmatically collect and analyze patient-level clinical, procedural, and outcome data from participating centers in Italy and Poland on the use of the PERCUTEK Tycheseal™ stent-graft system for the endovascular repair of abdominal aortic aneurysms. The study aims to generate high-quality, real-world evidence on the technical success, safety, and mid-term outcomes of the device.
Study Design This is a pragmatic, observational, multicenter physician-initiated registry that will collect patient-level data for all eligible patients undergoing PERCUTEK Tycheseal™ device implantation. Each site will enter data into a standardized paper case report form (CRF), including demographic, anatomical, procedural, and follow-up variables. Sites will be expected to comply with data entry timelines and quality control checks. The total projected enrollment is 120-200 patients across all sites over an expected 18 month inclusion period.
The target enrollment is 120-200 patients across all participating sites.
Eligibility criteria
Qualifiers
Morphologically suitable aneurysm
Neck length ≥ 10 mm
Neck diameter suitable for 20-36 mm body (considering 10-20% of oversizing)
Neck angle: infrarenal ≤ 75°
Disqualifiers
Anatomical unsuitability
Subject has a life expectancy < 1 year
Circumferential thrombus in neck
Ruptured aneurysm
Trial design
Treatments tested in this trial
- Not listed